Explore the vast range of titles available.

Column loss is a type of damage that can occur in frame structures subjected to explosions or impacts. The response of such structures largely depends on the capacity of the assembly of elements and on the inertia effects due to the sudden nature of the phenomenon. Frame structures are able to develop various resisting mechanisms that prevent the collapse to progress. The assessment of the robustness often requires complex and detailed numerical modelling. For the preliminary design of a robust frame, simplified methods to assess the effectiveness of the redistribution of the loads after the removal of a member are welcome. In the present paper, an approach based on the idealisation of the damaged structure into a single degree-of-freedom system with an elastic-plastic compliance law is proposed. The output of the method is the dynamic response of a target point, which can serve for assessing the residual safety of the structure. Comparing the obtained results with the outputs of a more sophisticated FE (Finite Elements) analysis, a satisfying accuracy is found.

This paper proposes a dual adaptive Kalman filter to identify parameters of a dynamic system that may experience sudden damage by a dynamic excitation such as earthquake ground motion. While various filter techniques have been utilized to estimate system’s states, parameters, input (force), or their combinations, the filter proposed in this paper focuses on tracking parameters that may change suddenly using sparse measurements. First, an advanced state-space model of parameter estimation employing a regularization technique is developed to overcome the lack of information in sparse measurements. To avoid inaccurate or biased estimation by conventional filters that use covariance matrices representing time-invariant artificial noises, this paper proposes a dual adaptive filtering, whose slave filter corrects the covariance of the artificial measurement noises in the master filter at every time-step. Since it is generally impossible to tune the proposed dual filter due to sensitivity with respect to parameters selected to describe artificial noises, particle swarm optimization (PSO) is adopted to facilitate optimal performance. Numerical investigations confirm the validity of the proposed method through comparison with other filters and emphasize the need for a thorough tuning process.

Purpose The paper aims to propose a stability analysis method based on region-of-attraction (ROA) overlapping to evaluate the flight stability of the possible sudden damage process and guarantee flight safety in extreme cases. Design/methodology/approach First, according to the two flight conditions before and after damage which the aircraft may encounter, flight dynamical models are built and fitted by polynomial equation for subsequent ROA analysis. And then, the ROA overlapping estimation method based on V-s iteration is presented to complete the stability analysis of such airplane sudden damage process. Findings Finally, in the presence of control surface damage, case aircraft flight stability is analyzed and simulated to verify the effectiveness of the proposed method. Practical implications The proposed method can be used for stability check during the aircraft control law design, or for further completing the design of the emergency stable controller design. Originality/value Compared with previous studies on sudden damage process of aircraft, to the best of the authors’ knowledge, this is one of the pioneer studies in which the ROA and ROA overlapping concept has been introduced. This study on stability analysis of aircraft sudden damage process could further develop the theory of emergency stable control.

Sudden cardiac arrests (SCA) and sudden cardiac deaths (SCD) are believed to account for a large proportion of deaths due to cardiovascular causes. The purpose of this study is to provide comprehensive information on the epidemiology of SCAs and SCDs after acute coronary syndrome. The incidence of SCA (including SCDs) was studied retrospectively among 10,316 consecutive patients undergoing invasive evaluation for acute coronary syndrome (ACS) between 2007 and 2018 at Tays Heart Hospital (sole provider of specialized cardiac care for a catchment area of over 0.5 million residents). Baseline and follow-up information was collected by combining information from the hospital's electronic health records, death certificate data, and a full-disclosure review of written patient records and accounts of the circumstances leading to death. During 12 years of follow-up, the cumulative incidence of SCAs (including SCDs) was 9.8% (0.8% annually) and that of SCDs 5.4% (0.5% annually). Cumulative incidence of SCAs in patients with ST-elevation myocardial infarction, non-ST-elevation myocardial infarction and unstable angina pectoris were: 11.9%,10.2% and 5.7% at 12 years. SCAs accounted for 30.5% (n = 528/1,732) of all deaths due to cardiovascular causes. The vast majority of SCAs (95.6%) occurred in patients without implantable cardioverter defibrillator (ICD) devices or among patients with no recurrent hospitalizations for coronary artery disease (89.1%). SCAs accounted for less than a third of all deaths due to cardiovascular causes among patients with previous ACS. Incidence of SCA is highest among STEMI and NSTEMI patients. After the hospital discharge, most of SCAs happen to NSTEMI patients.

Prompt coronary catheterization and revascularization have markedly improved the outcomes of myocardial infarction, but have also resulted in a growing number of surviving patients with permanent structural damage of the heart, which frequently leads to heart failure. There is an unmet clinical need for treatments for this condition 1 , particularly given the inability of cardiomyocytes to replicate and thereby regenerate the lost contractile tissue 2 . Here we show that expression of human microRNA-199a in infarcted pig hearts can stimulate cardiac repair. One month after myocardial infarction and delivery of this microRNA through an adeno-associated viral vector, treated animals showed marked improvements in both global and regional contractility, increased muscle mass and reduced scar size. These functional and morphological findings correlated with cardiomyocyte de-differentiation and proliferation. However, subsequent persistent and uncontrolled expression of the microRNA resulted in sudden arrhythmic death of most of the treated pigs. Such events were concurrent with myocardial infiltration of proliferating cells displaying a poorly differentiated myoblastic phenotype. These results show that achieving cardiac repair through the stimulation of endogenous cardiomyocyte proliferation is attainable in large mammals, however dosage of this therapy needs to be tightly controlled. MicroRNAs delivered by adeno-associated viral vectors improve global and regional contractility, increase muscle mass and reduce scar size in a porcine model of myocardial infarction.

Customized Cu3(PO4)2 and CuO nanosheets and commercial CuO nanoparticles were investigated for micronutrient delivery and suppression of soybean sudden death syndrome. An ab initio thermodynamics approach modelled how material morphology and matrix effects control the nutrient release. Infection reduced the biomass and photosynthesis by 70.3 and 60%, respectively; the foliar application of nanoscale Cu reversed this damage. Disease-induced changes in the antioxidant enzyme activity and fatty acid profile were also alleviated by Cu amendment. The transcription of two dozen defence- and health-related genes correlates a nanoscale Cu-enhanced innate disease response to reduced pathogenicity and increased growth. Cu-based nanosheets exhibited a greater disease suppression than that of CuO nanoparticles due to a greater leaf surface affinity and Cu dissolution, as determined computationally and experimentally. The findings highlight the importance and tunability of nanomaterial properties, such as morphology, composition and dissolution. The early seedling foliar application of nanoscale Cu to modulate nutrition and enhance immunity offers a great potential for sustainable agriculture.Foliar application of different forms of nanoscale copper to plant seedlings induces material-specific biochemical and molecular changes in root tissue that stimulate plant defence against soybean sudden death syndrome.

The comorbidities related to obesity are already extensive, but as the prevalence of obesity increases globally, so do the number of its associated conditions. The relationship between hearing impairment and obesity is a relatively recent research interest, but is significant as both conditions have the ability to substantially reduce an individual’s quality of life both physically and psychologically. Obesity has a significant effect on vascular function, and this may have an impact on highly vascular organs such as the auditory system. This review aims to provide an overview of the existing literature surrounding the association between hearing loss and obesity, in order to emphasise these two highly prevalent conditions, and to identify areas of further investigation. Our literature search identified a total of 298 articles with 11 articles of relevance to the review. The existing literature in this area is sparse, with interest ranging from obesity and its links to age-related hearing impairment (ARHI) and sudden sensorineural hearing loss (SSNHL), to animal models and genetic syndromes that incorporate both disorders. A key hypothesis for the underlying mechanism for the relationship between obesity and hearing loss is that of vasoconstriction in the inner ear, whereby strain on the capillary walls due to excess adipose tissue causes damage to the delicate inner ear system. The identified articles in this review have not established a causal relationship between obesity and hearing impairment. Further research is required to examine the emerging association between obesity and hearing impairment, and identify its potential underlying mechanisms.

Background Filiano and Kinney proposed a triple-risk model for the sudden infant death syndrome (SIDS) that involves the intersection of three risks: (1) a vulnerable infant, (2) a critical developmental period in homeostatic control, and (3) an exogenous stressor(s). The primary evidence for the role of a critical developmental period in SIDS etiology is the peak of cases around the third month of life. Independently, several studies pointed to correlation between gestational age and age at death in SIDS, but used that to assess the SIDS risk for preterm infants, ignoring further ramifications. Methods We did a detailed analysis of CDC data spanning over two decades (1983–2011). We focused not only on the correlation between two age variables (gestational and age at death), but also on the possibility of misdiagnosis. Also, we attempted to account for potential biases in the data induced by the ICD-9/ICD-190 transition or the “Back to Sleep” campaign. Results The peak of deaths in the third month of life, that was the main argument for the role of the critical development period, wasn’t unique to SIDS. However, we confirmed an almost linear and negative correlation between gestational age and the week of death due to SIDS. This pattern (slope of correlation < 0 and significance of correlation p  < 0.05) is characteristic of SIDS among all diseases analyzed in the study. Conclusions We interpret the results as the evidence of the role of the critical development period in SIDS etiology. Possibly more attention in the future research should be put to theories that are based on homeostatic control.

Sudden unexpected postnatal collapse (SUPC) is a sudden collapse of the clinical conditions of a full-term or near-term newborn, within the first 7 days of life, that requires resuscitation with positive ventilation and who either dies, has hypoxic-ischemic encephalopathy, or requires intensive care. The incidence of SUPC is very low, and most often presents a negative prognosis. The BUB1B gene is a mitotic checkpoint of serine/threonine kinase B that encodes a protein crucial for maintaining the correct number of chromosomes during cell division. Mutations in the BUB1B gene are linked to mosaic variegated aneuploidy syndrome 1 (MVA1), a rare autosomal recessive disorder characterized by diffuse mosaic aneuploidies involving several chromosomes and tissues. This paper discusses a case of a newborn who had a spontaneous delivery. After 2 h and 10 min, the infant showed generalized hypotonia and cyanosis, and his doctors performed orotracheal intubation, cardiac massage, pharmacological hemodynamic therapy, mechanical ventilation, antibiotic therapy, and hypothermic treatment. The newborn was discharged after 5 months with the diagnosis of hypoxic-ischemic encephalopathy. Suspecting an SUPC, a complete genetic analysis was performed demonstrating a compound heterozygous mutations in the BUB1B gene. The newborn died at 6 months of life, 1 month after discharge. A complete autopsy was performed, determining that the cause of death was due to sepsis starting from a brocopneumonic process, with outcomes of hypoxic-ischemic encephalopathy (HIE). In this scenario, it is not possible to demonstrate the causal effect of this mutation, considering that it could play a causal or concausal role in the onset of SUPC. Further research based on multicenter studies, as well as on animal models, could be very useful to clarify the pathological effect of this mutation.

Methiopropamine (MPA) is a structural analogue of methamphetamine and belongs to the category of the novel psychoactive substances. To the best of our knowledge, no experimental study has been performed to evaluate the organ damage evoked by MPA administration in an animal model. Therefore, the main purpose of the present study was to investigate the histological changes in CD-1 male mice following the chronic administration of MPA. MPA-chronically treated mice showed myocardial damage with features consistent with repeated episodes of ischemia and a pattern of kidney damage and gastrointestinal ischemia, with ischemic-necrotic lesions of variable extent. In agreement with the analogies between MPA and methamphetamine, we link organ damage secondary to MPA administration to the vasoconstrictive effect exhibited by both compounds. Chronically MPA-treated mice did not show changes in body weight, food intake, thermoregulation, muscular strength and motor coordination in the accelerod test. However, acute MPA administration significantly increased their heart rate and promoted vasoconstriction, which were associated with the sudden death of a subset of animals (40% of all chronically treated mice). In conclusion, the present study demonstrates that MPA consumption could induce health hazards, highlighting the risk of sudden catastrophic events; therefore, clinicians should be aware of these data and consider MPA screening when no other drug is identified by a urine drug screen.